Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Post by studpuppyon Mar 07, 2011 3:50am
413 Views
Post# 18242512

Why so surprised??

Why so surprised??this ipo crap has been in the works since november just like saurus mentionned, i remember very clearly when jp morgan started buying up everything on the open market when the price was in the $4.50s pre approval about 1 million shares give or take a few thousands and then we got approval and the shorts went higher, im assuming the shorts kicked in at around $6, so these guys made money on the way up, they kept capping it by enloading there shares and now they will get them back at discount again, guys scream and yell all you want this deal will go through, huss has been in bed with them since he got in, no one here on the board knew about the shorts until rusty showed up in january to let us know,now if you really are who you say you are well kudos to you rusty, and i tip off my hat to you , i dont know any ceo's of any sort going on stockhouse everyday at anytime of the day to post information about a company, bravo!!
probably during the weekend huss and company had a huge party to celebrate a job well done by manipulating the stock price, but dont worry guys there will be a nice pump and dump once we get listed on nasdaq, i've been long on th but my patience has run out, i have considerably reduced my position on th since approval to move on to other opportunities, i will keep a couple of thousand shares and forget about them but the rest well at the next run goodbye, i know its a bummer but dont sell your shares at these levels hold on a bit longer!!
glta regards stud
like they say in good french :on s'est fait fourrer d'aplomb
Bullboard Posts